Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 3.37 CHF 2.12% Market Closed
Market Cap: 136m CHF

Intrinsic Value

The intrinsic value of one MOLN stock under the Base Case scenario is 5.99 CHF. Compared to the current market price of 3.37 CHF, Molecular Partners AG is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MOLN Intrinsic Value
5.99 CHF
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Molecular Partners AG

What is Valuation History?
Ask AI Assistant
What other research platforms think about MOLN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MOLN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Molecular Partners AG.

Explain Valuation
Compare MOLN to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MOLN?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Molecular Partners AG

Current Assets 109m
Cash & Short-Term Investments 104.5m
Receivables 2.1m
Other Current Assets 2.3m
Non-Current Assets 3.2m
PP&E 3.2m
Intangibles 5k
Current Liabilities 11.7m
Accounts Payable 2.1m
Accrued Liabilities 8.4m
Other Current Liabilities 1.2m
Non-Current Liabilities 4.9m
Long-Term Debt 308k
Other Non-Current Liabilities 4.6m
Efficiency

Free Cash Flow Analysis
Molecular Partners AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Molecular Partners AG

Revenue
0 CHF
Operating Expenses
-57.6m CHF
Operating Income
-57.6m CHF
Other Expenses
-2.7m CHF
Net Income
-60.2m CHF
Fundamental Scores

MOLN Profitability Score
Profitability Due Diligence

Molecular Partners AG's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Sustainable 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Molecular Partners AG's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

MOLN Solvency Score
Solvency Due Diligence

Molecular Partners AG's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
55/100
Solvency
Score

Molecular Partners AG's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
6.06 CHF
80% Upside
Average
Price Target
10.71 CHF
218% Upside
Highest
Price Target
15.75 CHF
367% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Molecular Partners AG
does not pay dividends
Shareholder Yield

Current shareholder yield for MOLN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

MOLN News

Other Videos
What is the Intrinsic Value of one MOLN stock?

The intrinsic value of one MOLN stock under the Base Case scenario is 5.99 CHF.

Is MOLN stock undervalued or overvalued?

Compared to the current market price of 3.37 CHF, Molecular Partners AG is Undervalued by 44%.

Back to Top